Want to see COCH full AI Analyst Report?
Envoy Medical (COCH) Ratios
127 Followers
Envoy Medical Ratios
COCH's free cash flow for Q2 2026 was $-5.46M. For the 2026 fiscal year, COCH's free cash flow was decreased by $-6.00K and operating cash flow was $-5.46M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.54 | 1.24 | 1.02 | 0.65 | 1.76 |
| Quick Ratio | 0.41 | 1.02 | 0.83 | 0.14 | 0.99 |
| Cash Ratio | 0.32 | 0.73 | 0.58 | 0.07 | 0.81 |
| Solvency Ratio | -1.15 | -0.68 | -2.96 | -0.41 | -0.18 |
| Operating Cash Flow Ratio | -1.57 | -2.38 | -2.35 | -3.50 | -5.01 |
| Short-Term Operating Cash Flow Coverage | -104.60 | 0.00 | 0.00 | -19.65 | 0.00 |
| Net Current Asset Value | $ -14.05M | $ -21.00M | $ -2.59M | $ -37.10M | $ -45.15M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 1.70 | 0.07 | 13.51 | 8.95 |
| Debt-to-Equity Ratio | -0.08 | -1.04 | -0.32 | -0.95 | -0.52 |
| Debt-to-Capital Ratio | -0.08 | 24.01 | -0.46 | -20.80 | -1.09 |
| Long-Term Debt-to-Capital Ratio | -0.07 | -148.54 | 0.00 | -11.94 | -1.09 |
| Financial Leverage Ratio | -0.73 | -0.61 | -4.66 | -0.07 | -0.06 |
| Debt Service Coverage Ratio | -12.39 | -24.27 | 0.00 | -19.27 | 0.00 |
| Interest Coverage Ratio | -14.01 | -23.60 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.06 | 0.70 | 0.00 | 0.33 | 0.24 |
| Interest Debt Per Share | 1.08 | 1.09 | 0.04 | 3.40 | 2.31 |
| Net Debt to EBITDA | 0.13 | -0.72 | 0.12 | -3.98 | -3.29 |
| Profitability Margins | |||||
| Gross Profit Margin | -262.66% | -229.78% | -149.68% | -110.13% | -148.06% |
| EBIT Margin | -9197.51% | -8879.56% | -9468.99% | -3673.42% | -2216.45% |
| EBITDA Margin | -9072.20% | -8802.67% | -9426.90% | -3641.77% | -2193.55% |
| Operating Profit Margin | -9240.66% | -8558.22% | -5809.81% | -3673.42% | -2216.45% |
| Pretax Profit Margin | -9857.26% | -9242.22% | -9468.99% | -6718.57% | -2798.39% |
| Net Profit Margin | -9857.26% | -9242.22% | -9468.99% | -6718.57% | -2798.39% |
| Continuous Operations Profit Margin | -9857.26% | -9242.22% | -9468.99% | -6718.57% | -2798.39% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 106.67% | 107.99% | 162.98% | 182.90% | 126.26% |
| Return on Assets (ROA) | -277.59% | -180.23% | -361.77% | -622.97% | -330.60% |
| Return on Equity (ROE) | 201.89% | 110.37% | 1684.80% | 43.99% | 19.29% |
| Return on Capital Employed (ROCE) | 741.34% | -481.40% | -1861.97% | -23529.73% | -554.11% |
| Return on Invested Capital (ROIC) | 786.93% | -464.78% | -1604.81% | -1427.21% | -554.11% |
| Return on Tangible Assets | -277.59% | -180.23% | -361.77% | -622.97% | -330.60% |
| Earnings Yield | -154.51% | -77.39% | -131.65% | -15.65% | -8.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.09 | 0.28 | 4.51 | 5.78 | 3.52 |
| Payables Turnover | 0.30 | 0.45 | 0.51 | 0.50 | 1.16 |
| Inventory Turnover | 0.57 | 0.43 | 0.56 | 0.38 | 0.73 |
| Fixed Asset Turnover | 0.13 | 0.10 | 0.39 | 0.26 | 1.65 |
| Asset Turnover | 0.03 | 0.02 | 0.04 | 0.09 | 0.12 |
| Working Capital Turnover Ratio | -0.14 | 0.22 | -0.90 | 2.62 | 0.63 |
| Cash Conversion Cycle | -522.32 | 1354.52 | 11.46 | 277.16 | 293.00 |
| Days of Sales Outstanding | 51.49 | 1326.98 | 80.85 | 63.14 | 103.61 |
| Days of Inventory Outstanding | 645.64 | 840.19 | 649.51 | 949.15 | 503.12 |
| Days of Payables Outstanding | 1219.45 | 812.64 | 718.90 | 735.13 | 313.74 |
| Operating Cycle | 697.13 | 2167.17 | 730.36 | 1012.29 | 606.73 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -7.83 | -0.96 | -1.36 | -0.87 | -0.68 |
| Free Cash Flow Per Share | -7.90 | -1.01 | -1.37 | -0.89 | -0.70 |
| Dividend Paid and CapEx Coverage Ratio | -9.11 | -5.24 | -111.71 | -40.39 | -55.49 |
| Capital Expenditure Coverage Ratio | -101.68 | -18.32 | -111.71 | -40.39 | -55.49 |
| Operating Cash Flow Coverage Ratio | -19.81 | -0.91 | -30.41 | -0.25 | -0.30 |
| Operating Cash Flow to Sales Ratio | -75.52 | -79.77 | -54.09 | -37.15 | -22.37 |
| Free Cash Flow Yield | -119.55% | -70.45% | -75.87% | -8.87% | -7.14% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.54 | -1.29 | -0.76 | -6.39 | -11.40 |
| Price-to-Sales (P/S) Ratio | 63.80 | 119.42 | 71.93 | 429.30 | 319.03 |
| Price-to-Book (P/B) Ratio | -1.31 | -1.43 | -12.80 | -2.81 | -2.20 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.84 | -1.42 | -1.32 | -11.28 | -14.01 |
| Price-to-Operating Cash Flow Ratio | -0.84 | -1.50 | -1.33 | -11.56 | -14.26 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | 0.03 | -0.01 | -0.13 | 0.00 |
| Enterprise Value Multiple | -0.57 | -2.07 | -0.64 | -15.77 | -17.83 |
| Enterprise Value | 12.55M | 41.05M | 19.07M | 136.10M | 121.26M |
| EV to EBITDA | -0.57 | -2.07 | -0.64 | -15.77 | -17.83 |
| EV to Sales | 52.09 | 182.43 | 60.36 | 574.24 | 391.15 |
| EV to Free Cash Flow | -0.68 | -2.17 | -1.11 | -15.08 | -17.17 |
| EV to Operating Cash Flow | -0.69 | -2.29 | -1.12 | -15.46 | -17.48 |
| Tangible Book Value Per Share | -5.06 | -1.00 | -0.14 | -3.56 | -4.43 |
| Shareholders’ Equity Per Share | -5.06 | -1.00 | -0.14 | -3.56 | -4.43 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.10 | 0.01 | 0.03 | 0.02 | 0.03 |
| Net Income Per Share | -10.21 | -1.11 | -2.38 | -1.57 | -0.85 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.07 | 1.04 | 1.00 | 1.83 | 1.26 |
| Research & Development to Revenue | 51.81 | 45.24 | 28.34 | 20.99 | 12.71 |
| SG&A to Revenue | 37.97 | 38.04 | 22.99 | 10.91 | 7.98 |
| Stock-Based Compensation to Revenue | 0.37 | 0.00 | 4.98 | 0.00 | 0.00 |
| Income Quality | 0.77 | 0.80 | 0.57 | 0.55 | 0.80 |
Currency in USD
